Project Details
Description
A Phase Ib/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Status | Finished |
---|---|
Effective start/end date | 8/7/13 → 12/31/16 |
Funding
- ALTOR BIOSCIENCE LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.